For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
The stock is in a well-established, long-term rising trend above the technical support level at 24.95 EUR
Weaknesses
The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
The group shows a rather high level of debt in proportion to its EBITDA.
With an enterprise value anticipated at 5.46 times the sales for the current fiscal year, the company turns out to be overvalued.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 79.05 times its estimated earnings per share for the ongoing year.
The company is not the most generous with respect to shareholders' compensation.
Ratings chart
Sector Medical Equipment, Supplies & Distribution - Other
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
